N. Hebert-croteau et al., Compliance with consensus recommendations for the treatment of early stagebreast carcinoma in elderly women, CANCER, 85(5), 1999, pp. 1104-1113
BACKGROUND. The goal of this study was to assess variations with age in the
management of breast carcinoma and to identify determinants of care receiv
ed.
METHODS. A stratified random sample was selected among women age greater th
an or equal to 50 newly diagnosed with lymph node negative breast carcinoma
in Quebec in 1988, 1991, and 1993. Information was abstracted from medical
charts. Predictors of definitive locoregional treatment (total mastectomy
with lymph node dissection or breast-conserving surgery with both axillary
lymph node dissection and radiation therapy) were identified by multiple lo
gistic regression analysis.
RESULTS. Overall, 1174 patients age greater than or equal to 50 Fears with
breast carcinoma were included. Women age greater than or equal to 70 years
were much less likely to receive definitive locoregional treatment compare
d with women ages 50-69 years (48.7% vs. 83.5%; P < 0.0001). Older women we
re less likely to undergo surgery with breast preservation (76.7% vs. 86.3%
; P < 0.0001), radiation therapy (54.7% vs. 90.5%; P < 0.0001), dissection
of the axillary lymph nodes (55.6% vs. 86.3%; P < 0.0001), or chemotherapy
(1.2% vs. 13.9%; P < 0.0001), but not treatment with tamoxifen (66.4% vs. 6
4.7%; P = 0.41). adjusting for comorbidity and other characteristics relate
d to the disease, the hospital, and the attending physician, age remained a
strong determinant of the probability of receiving definitive locoregional
treatment (odds ratio [OR], 0.14; 95% confidence interval [95% CI], 0.12-0
.18 for women age greater than or equal to 70 years vs. women ages 50-69 ye
ars). The same association was observed when women who did not undergo lymp
h node dissection but who received systemic adjuvant treatment were conside
red to have received definitive therapy (OR, 0.13; 95% CI, 0.10-0.17) for w
omen age greater than or equal to 70 years vs, women ages 50-69 years).
CONCLUSIONS. Less aggressive patterns of care are provided to elderly breas
t carcinoma patients. independent of comorbidity. This could explain, at le
ast in part, the sustained breast carcinoma mortality in this population. C
ancer 1999;85:1104-13. (C) 1999 American Cancer Society.